Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study

NCT06355193 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT06355193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study
Lead sponsor
Central South University
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2022
Completion date
December 31, 2022
Enrollment
253 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of mild cases of covid-19